US Markets

Moderna in talks with Japan to supply 40 mln doses of COVID-19 vaccine

Credit: REUTERS/BRIAN SNYDER

Moderna Inc said on Friday it was in talks with Japan's government to potentially supply 40 million or more doses of its COVID-19 vaccine candidate.

Aug 28 (Reuters) - Moderna Inc MRNA.O said on Friday it was in talks with Japan's government to potentially supply 40 million or more doses of its COVID-19 vaccine candidate.

The vaccine candidate, mRNA-1273, would be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical Co Ltd 4502.T, beginning in the first half of 2021, if it receives regulatory approval.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Ramakrishnan M.)

((manojna.kalyani@thomsonreuters.com; +91 8061822700;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRNA

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More